Tensions Simmer In Sanofi, Genzyme Bid Battle
A hostile-takeover battle between Sanofi-Aventis SA and Genzyme Corp. heated up Friday, with Sanofi slamming a claim by Genzyme that the French drugmaker's final $18.5 billion tender offer was considerably lower...To view the full article, register now.
Already a subscriber? Click here to view full article